+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 21Years - 65Years
All Genders
ID07369102

Esketamine Nasal Spray with or without Supportive Therapy for Adults with Treatment-Resistant Depression A Randomized Controlled Phase 4 Study

Led by University of Puerto Rico · Updated on 2026-01-27

20

Participants Needed

2

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effects of esketamine Spravato, an FDA-approved nasal spray, on adults with treatment-resistant depression TRD. The study aims to determine if adding therapeutic support sessions before and after esketamine doses can improve mood, functioning, and overall treatment experience. This is a randomized controlled trial comparing esketamine with and without these additional support sessions. All participants will receive intranasal esketamine twice weekly during an acute 4-week phase, then weekly or biweekly during a maintenance phase lasting up to 8 weeks based on clinical response. One group will also receive brief, structured preparation and integration therapy sessions before and after each dose, designed to support emotional processing and meaning-making. The other group will receive standard clinical monitoring without extra psychotherapeutic support. During the 8-week study, participants will attend dosing sessions with monitoring for at least two hours after each dose. Researchers will assess depression severity using the Montgomery-sberg Depression Rating Scale MADRS along with measures of emotional regulation, treatment acceptability, and safety. Follow-up assessments will monitor treatment response, remission, relapse, and suicidal thoughts. The study is conducted under clinical supervision with informed consent and ethical approval.

CONDITIONS

Brief Title

Esketamine With or Without Integration Therapy for Treatment-Resistant Depression

Research Team

P

Paulina D Rullan-Farinacci, MD

K

Karen G Martinez-Gonzalez, MD, MSc

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here